These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18442228)

  • 1. On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.
    Costanzi S
    J Med Chem; 2008 May; 51(10):2907-14. PubMed ID: 18442228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
    Reynolds KA; Katritch V; Abagyan R
    J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study.
    Bera I; Laskar A; Ghoshal N
    J Mol Model; 2011 May; 17(5):1207-21. PubMed ID: 20661609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
    Cherezov V; Rosenbaum DM; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Kuhn P; Weis WI; Kobilka BK; Stevens RC
    Science; 2007 Nov; 318(5854):1258-65. PubMed ID: 17962520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoldGPCR: structure prediction protocol for the transmembrane domain of G protein-coupled receptors from class A.
    Michino M; Chen J; Stevens RC; Brooks CL
    Proteins; 2010 Aug; 78(10):2189-201. PubMed ID: 20544957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulations of a G protein-coupled receptor homology model predict dynamic features and a ligand binding site.
    Wolf S; Böckmann M; Höweler U; Schlitter J; Gerwert K
    FEBS Lett; 2008 Oct; 582(23-24):3335-42. PubMed ID: 18775703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization of G protein-coupled receptors.
    Salom D; Padayatti PS; Palczewski K
    Methods Cell Biol; 2013; 117():451-68. PubMed ID: 24143992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the active conformations of rhodopsin and the beta2-adrenergic receptor.
    Gouldson PR; Kidley NJ; Bywater RP; Psaroudakis G; Brooks HD; Diaz C; Shire D; Reynolds CA
    Proteins; 2004 Jul; 56(1):67-84. PubMed ID: 15162487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallizing thinking about the beta2-adrenergic receptor.
    Shukla AK; Sun JP; Lefkowitz RJ
    Mol Pharmacol; 2008 May; 73(5):1333-8. PubMed ID: 18239031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern homology modeling of G-protein coupled receptors: which structural template to use?
    Mobarec JC; Sanchez R; Filizola M
    J Med Chem; 2009 Aug; 52(16):5207-16. PubMed ID: 19627087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.
    Sabio M; Jones K; Topiol S
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5391-5. PubMed ID: 18829308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active state-like conformational elements in the beta2-AR and a photoactivated intermediate of rhodopsin identified by dynamic properties of GPCRs.
    Han DS; Wang SX; Weinstein H
    Biochemistry; 2008 Jul; 47(28):7317-21. PubMed ID: 18558776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand entry and exit pathways in the beta2-adrenergic receptor.
    Wang T; Duan Y
    J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor.
    Sherbiny FF; Schiedel AC; Maass A; Müller CE
    J Comput Aided Mol Des; 2009 Nov; 23(11):807-28. PubMed ID: 19757091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond rhodopsin: G protein-coupled receptor structure and modeling incorporating the beta2-adrenergic and adenosine A(2A) crystal structures.
    Tebben AJ; Schnur DM
    Methods Mol Biol; 2011; 672():359-86. PubMed ID: 20838977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of intracellular allosteric β
    Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
    Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
    Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
    J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.